Adderall and Taltz drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Adderall (amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate) and Taltz (ixekizumab). Common drug interactions include pneumonia among females and colitis among males.
The phase IV clinical study analyzes what interactions people have when they take Adderall and Taltz. It is created by eHealthMe based on reports of 29 people who take the same drugs from the FDA, and is updated regularly.
What is Adderall?
Adderall has active ingredients of amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate. It is often used in attention deficit hyperactivity disorder. eHealthMe is studying from 64,224 Adderall users. Check the latest studies of Adderall.
What is Taltz?
Taltz has active ingredients of ixekizumab. eHealthMe is studying from 29,777 Taltz users. Check the latest studies of Taltz.
29 people who take Adderall and Taltz together, and have interactions are studied.

What are the common drug interactions of Adderall and Taltz, by gender? *:
female:
- Pneumonia
- Dyspepsia (indigestion)
- Psoriasis (immune-mediated disease that affects the skin)
- Colonoscopy
- Diarrhoea
- Drug ineffective
- Gastrointestinal disorder (functional problems of gastrointestinal tract)
- Hospitalisation
- Psoriatic arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop)
- Red blood cell count decreased
male:
- Colitis (inflammation of colon)
- Injection site erythema (redness at injection site)
- Renal mass (mass in kidney)
- Respiratory tract infection
- Arthropathy
- Cardiac disorder
- Chest pain
- Diarrhoea
- Headache (pain in head)
- Hypertension (high blood pressure)
What are the common drug interactions of Adderall and Taltz, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Injection site erythema (redness at injection site)
- Injection site pruritus (severe itching at injection site)
20-29:
- Colitis (inflammation of colon)
- Prostatitis (inflammation of the prostate gland)
- Hydronephrosis (water inside the kidney)
- Lymphadenopathy (disease or enlargement of lymph nodes)
- Pyelonephritis (inflammation of kidney caused by bacteria)
- Renal infarct (kidney damage due to lack of blood supply)
- Renal mass (mass in kidney)
- Breast cancer
- Diarrhoea
- Eosinophilic cellulitis (recurrent pruritic or tender skin lesions)
30-39:
n/a
40-49:
- Abdominal pain upper
- Coccydynia (pain in the coccyx or tailbone area)
- Constipation
- Defaecation urgency (a sudden compelling urge to defecate)
- Diarrhoea
- Dyspepsia (indigestion)
- Haematochezia (passage of stools containing blood)
- Headache (pain in head)
- Mucous stools (mucous with stool)
- Proctalgia (pain in the rectum)
50-59:
- Burning sensation
- Diarrhoea haemorrhagic (bloody diarrhoea)
- Nasopharyngitis (inflammation of the nasopharynx)
60+:
- Depression suicidal (suicide depressive disorder)
- Diarrhoea
- Dyskinesia (abnormality or impairment of voluntary movement)
- Headache (pain in head)
- Paranoia (psychotic disorder characterized by delusions of persecution with or without grandeur)
- Vomiting
What are the existing conditions these people have? *
- Psoriasis (immune-mediated disease that affects the skin): 14 people, 48.28%
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 8 people, 27.59%
- Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 8 people, 27.59%
- Drowsiness: 6 people, 20.69%
- Cataplexy (loss of muscle tone accompanied by full conscious awareness): 5 people, 17.24%
- Weakness: 2 people, 6.90%
- High Blood Cholesterol: 2 people, 6.90%
- Blood Potassium Decreased: 2 people, 6.90%
- Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 2 people, 6.90%
- Depression: 2 people, 6.90%
* Approximation only. Some reports may have incomplete information.
Do you take Adderall and Taltz?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Adderall and Taltz:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Adderall:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Taltz:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Adderall and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Taltz and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on amphetamine aspartate; amphetamine sulfate; dextroamphetamine saccharate; dextroamphetamine sulfate and ixekizumab (the active ingredients of Adderall and Taltz, respectively), and Adderall and Taltz (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Sulfasalazine cause Mumps? - a second ago
- Metoclopramide and Emotional Distress for Men aged 50-59 - a second ago
- Cognitive Disorder in Neurontin, how severe and when it was recovered? - 6 seconds ago
- Aripiprazole and Respiratory Arrest for Women aged 60+ - 8 seconds ago
- Aripiprazole and Respiration Slowed Or Stopped for Women aged 60+ - 9 seconds ago
- Aripiprazole and Not Breathing for Women aged 60+ - 9 seconds ago
- Aripiprazole and Apnea for Women aged 60+ - 10 seconds ago
- Aripiprazole and Breathing - Slowed Or Stopped for Women aged 60+ - 10 seconds ago
- Sertraline Hydrochloride and Haemorrhage for Women aged 50-59 - 14 seconds ago
- Moxifloxacin Hydrochloride and Lidocaine Hydrochloride drug interactions for men aged 60+ - 17 seconds ago